119-HR5160

Stem Cell Therapeutic and Research Reauthorization Act of 2025

Last action was on 9-4-2025

Bill is currently in: House
Path to Law
House Senate President

Current status is Referred to the House Committee on Energy and Commerce.

View Official Bill Information at congress.gov

No users have voted for/against support on this bill yet. Be the first!


119th CONGRESS

1st Session

H. R. 5160

1. Short title
2. Reauthorization of the C.W. Bill Young Cell Transplantation Program
3. Cord blood inventory

1. Short title

This Act may be cited as the "Stem Cell Therapeutic and Research Reauthorization Act of 2025".


2. Reauthorization of the C.W. Bill Young Cell Transplantation Program

Section 379B of the Public Health Service Act (42 U.S.C. 274m) is amended—

(1) - by striking "appropriated $31,009,000" and inserting the following:

(1) - $31,009,000

(2) - in paragraph (1), as so inserted, by striking the period at the end and inserting "; and"; and

(3) - by adding at the end the following:

(2) - $33,009,000 for each of fiscal years 2027 through 2031.

3. Cord blood inventory

Section 2(g) of the Stem Cell Therapeutic and Research Act of 2005 (42 U.S.C. 274k note) is amended by striking "2026" and inserting "2031".